virtual screening and combinatorial fragment ... - Semantic Scholar
Recommend Documents
Jan 25, 2018 - ribosome, the cell wall synthesis and DNA gyrase that comprise clinical ...... Thereafter, Bcl-2 inhibitor venetoclax has been approved for the.
Hongying, Y.; Heidi, G.; Kristine, I.; Wendy, C.; Andre, I.; Siva,. L.; Oliver, M.; David, A. S.; Jerrold, M. O.; Michael, R. J.; Peter,. J. E.; Christoph, H. W. Nature Letter.
Sep 17, 2015 - filtering procedure was conducted with the Ligfilter utility implemented in Maestro 9.6 [47]. This filtering procedure yielded 1646 and 2955 ...
Blommers, Paul Selzer and Edgar Jacoby. Novartis Institutes of ...... Hajduk, P. J.; Dinges, J.; Miknis, G. F.; Merlock, M.; Middleton,. T.; Kempf, D. J.; Egan, D. A.; ...
Mar 25, 2016 - Aquaporins (AQPs) are membrane proteins that permeabilize cellular membranes to water [1â3]. In humans, 13 AQPs have been identified [4], ...
Nov 9, 2011 - PARP1 . Virtual screening. Introduction. The fragment approach in drug discovery. The target-based drug discovery (TBDD) is one of the.
Apr 9, 2010 - benefit the fields of chemical genomics and drug discovery. We have developed a ... developing inhibitors in such cases is achieving selectivity and other desired ... the development and evaluation of such a method, making use of a mole
designing potent inhibitors of purine salvage in Giardia parasites. As a second step in this .... better tailored for the GPRT purine binding site than our starting phthalimides. ..... 282:875â889. 30. Walters, W. P., M. T. Stahl, and M. A. Murcko.
Jul 16, 2015 - (2015) DARC 2.0: Improved Docking and Virtual. Screening at ... tom) than their counterparts engaging âtraditionalâ targets [21]. An ancillary ...
Feb 2, 2012 - Dopa decarboxylase (DDC), a pyridoxal 59-phosphate (PLP) enzyme ...... tyrosine 332 to phenylalanine converts dopa decarboxylase into a ...
Given an instance and a feasible solution, we can easily ... instance G the set of feasible solutions are the ..... Indeed, take any (inclusion-wise) maximal match-.
Apr 17, 2015 - plete SAR analysis. The virtual .... Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997; 387.
Abstract: We review the prominent technologies in virtual screening, and their applications in drug discovery. ..... represented as a set of 3 or 4 pharmacophoric centers forming a triangle or ...... We will henceforth call this vector the scoring ..
successful applicability of the fragment discovery concept for the identification of new ..... In parallel with the development of channel SPR sensors, studies by Knoll and others [62 ..... Induced Formation of Neuraminidase Inhibitors From in Vitro.
Dec 5, 2013 - Structural Characterization of a Therapeutic Anti-. Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites.
Karuna Kumar Mortha2 and Shib Das Banerjee4 ..... and Lady Tata Memorial Trust. Special thanks to ... Sunila S, Thimmaiah K N, Karuna Kumar M, Toole B P &.
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disease which is most often caused by a deficiency in steroid 21-hydroxylase. The disease is ...
Dec 1, 1998 - ... General Hospital Cancer Center, and Harvard Medical School, ... 02129,1 and Department of Microbiology and Molecular Genetics, Markey.
Jun 24, 2015 - we develop the fundamentals of combinatorial game theory and focus ..... For example, the simplest game is the endgame 0 := {|} with no ...
Aug 16, 2005 - and discussions during the preparation of this manuscript. P.M. also wants to thank Profs. Rodney Scott,. John Forbes and Alan Coates for ...
details can be found in (Shai 1997, Shai and Preiss 1999b) or books on graph .... weights of the edges) from the current vertex to the target vertex (Shai 1997).
Jan 26, 2010 - Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance. Jing Zhanga,1, Tingjun Houb,1, Wei Wangc ...
Nonparametric Bayesian Inference (Theme I) ... in our nonparametric setting, it means that a stochastic process can have ... against in the De Finetti setup? 8 ...
virtual screening and combinatorial fragment ... - Semantic Scholar
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). OncoTargets and Therapy 2017:10 2365.
OncoTargets and Therapy
Dovepress open access to scientific and medical research
Corrigendum
Open Access Full Text Article
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum] Pathan AAK, Panthi B, Khan Z, et al. OncoTargets and Therapy. 2016;9:2575–2584. On page 2582, panel A, B, C of Figure 5 had typographical and color issues. The correct images are as follows: